Navigation Links
'Watchful Waiting' Often Best Strategy for Slow-Moving Prostate Cancer
Date:6/18/2010

Surgery, radiation not always ideal for many with low risk disease, researchers find

FRIDAY, June 18 (HealthDay News) -- For patients with prostate cancer that has a low risk of progression, active surveillance, also known as "watchful waiting," may be a suitable treatment option, according to a large-scale study from Sweden.

The issue of how (or whether) to treat localized prostate cancer is controversial because, especially for older men, the tumor may not progress far enough to cause real trouble during their remaining expected lifespan. In those cases, deferring treatment until there are signs of disease progression may be the better option.

The researchers looked at almost 6,900 patients from the National Prostate Cancer Registry Sweden, age 70 or younger, who had localized prostate cancer and a low or intermediate risk that the cancer would progress. From 1997 through December 2002, over 2,000 patients were assigned to active surveillance, close to 3,400 underwent radical prostatectomy (removal of the prostate and some surrounding tissue), and more than 1,400 received radiation therapy.

After a median follow-up of just over 8 years, the surveillance group had a much higher death rate from causes other than prostate cancer -- 19.2 percent, compared with 6.8 percent in the prostatectomy group and 10.9 percent in the radiation therapy group.

This suggests that patients with a shorter life expectancy were more often selected for active surveillance rather than surgery or radiation therapy, the researchers said.

The patients who underwent surgery for prostate cancer had a lower risk of dying from prostate cancer than those in the active surveillance group. However, the difference in absolute risk of patients dying from prostate cancer was very small -- only 1.2 percent after 10 years of follow-up.

The researchers concluded that, based on these findings, active surveillance is the best strategy for many patients with low-risk prostate cancer.

"With a 10-year prostate cancer-specific mortality of less than three percent for patients with low-risk prostate cancer on surveillance, this strategy appears to be suitable for many of these men," wrote Dr. Par Stattin, of Umea University, and colleagues.

The study was published online June 18 in the Journal of the National Cancer Institute.

More information

The U.S. Agency for Healthcare Research and Quality has more about treatment of localized prostate cancer.



-- Robert Preidt



SOURCE: Journal of the National Cancer Institute, June 18, 2010, news release.


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Waiting to Clamp the Umbilical Cord May Be Better for Babies
2. Waiting Safe for Some at Risk of Glaucoma
3. Xyngular™ Distributors Continue Waiting For Xyngular Xyng™ As Zija's XM3™ "Happy Pill" Reaches Record Sales
4. Trustmark and HealthFitness Announce Early Termination of Hart-Scott-Rodino Waiting Period
5. Get Vaccinated Against a Second Wave of H1N1 Flu for Only $15 And no Waiting in Long Lines
6. Women Arent Waiting to Seek Infertility Help
7. Lymphoma Survivors Often Miss Out on Follow-Up
8. UNC study helps explain why black patients with lung cancer have surgery less often than whites
9. Most Doctors Giving Pap Test Too Often
10. Putting New Medical Guidelines Into Practice Often Difficult
11. Major Depression Often Follows Brain Injury
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
'Watchful Waiting' Often Best Strategy for Slow-Moving Prostate Cancer
(Date:5/27/2016)... ... 27, 2016 , ... W.S. Badger Co. Inc ., the maker of ... recognized as one of the best small businesses for new dads by Fatherly, the ... small businesses providing progressive benefits to new parents on the organization’s 2016 Best ...
(Date:5/27/2016)... ... May 27, 2016 , ... In response ... many who are unaware of the plight of aphasia. In collaboration with the ... “Stroke Awareness” campaign. , The link between stroke and aphasia is relatively unknown, ...
(Date:5/27/2016)... ... May 27, 2016 , ... With a ... medical and food industries. Aside from its GMP accreditation, Validation Center is also ... successfully certified products, services and staff. , Validation Center is ISO17025 accredited and ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... outcomes, hosted members and suppliers for its inaugural Member Conference at the Paris ... mission of elevating the operational health of America’s healthcare providers. , The conference ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cardiac arrhythmia is ... impact on long-term patient survival, reports a team of UPMC researchers in the ... in the Journal of Thoracic and Cardiovascular Surgery, provide critical information that will ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... New Zealand , May 24, 2016 ... and informatics solutions for the healthcare sector, has been named ... New Zealand Hi-Tech Awards 2016. Dr Bruce ... fantastic acknowledgement for our team.  It,s really good to be ... burden healthcare internationally. Our products are used in 35 countries ...
(Date:5/24/2016)... , May 24, 2016  Joe Marziani has joined VMS BioMarketing as senior ... executive officer, today. In his new role, Marziani will lead the company,s business development ... professionals to improve outcomes. Photo - http://photos.prnewswire.com/prnh/20160523/371089 ... ... ...
(Date:5/24/2016)... 24, 2016 ... , la première endoprothèse à double thérapie ... l,intervention portant sur les membres inférieurs et ... OrbusNeich, entreprise mondiale spécialisée dans la fourniture ... vie, a élargi son portefeuille pour inclure ...
Breaking Medicine Technology: